TG Therapeutics, Inc. (TGTX)

TG Therapeutics Revenue

In the year 2023, TG Therapeutics had annual revenue of $233.66M with 8,290.02% growth. Revenue in the quarter ending December 31, 2023 was $43.97M with 54,863.75% year-over-year growth.

• Revenue (ttm): $233.66M
• Revenue Growth: +8,290.02%
• P/S Ratio: 10.71
• Revenue / Employee: $885,083
• Employees: 264
• Market Cap: 2.50B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	233.66M	230.88M	8,290.02%
Dec 31, 2022	2.79M	-3.90M	-58.36%
Dec 31, 2021	6.69M	6.54M	4,300.66%
Dec 31, 2020	152.00K	-	-
Dec 31, 2019	152.00K	-	-
Dec 31, 2018	152.00K	-	-
Dec 31, 2017	152.00K	-	-
Dec 31, 2016	152.00K	-	-
Dec 31, 2015	152.00K	-	-
Dec 31, 2014	152.00K	-381.00	-0.25%
Dec 31, 2013	152.38K	133.33K	699.98%
Dec 31, 2012	19.05K	-	-
Dec 31, 2011	0	-	-
Dec 31, 2010	0	-	-
Dec 31, 2009	0	-	-
Dec 31, 2008	0	-	-
Dec 31, 2007	0	-	-
Dec 31, 2006	0	-	-
Dec 31, 2005	0	-	-
Dec 31, 2004	0	-	-
Dec 31, 2003	0	-	-
Aug 1, 2002	0	-	-
Dec 31, 2001	2.71M	-2.65M	-49.39%
Dec 31, 2000	5.36M	4.20M	362.15%
Dec 31, 1999	1.16M	-1.34M	-53.62%
Dec 31, 1998	2.50M	2.50M	109,165.73%
Dec 31, 1997	2.29K	-95.36K	-97.66%
Dec 31, 1996	97.64K	-	-
Dec 31, 1995	0	-	-
Dec 31, 1994	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.